Search Results for 'Lvef'

Lvef published presentations and documents on DocSlides.

Efficacy of beta-blockers in heart failure according to left ventricular ejection fraction
Efficacy of beta-blockers in heart failure according to left ventricular ejection fraction
by jaena
An individual patient level analysis of double-bli...
Updated cumulative results of treatment with
Updated cumulative results of treatment with
by Younggunner
mavacamten. from the EXPLORER-LTE cohort of the M...
AHA Clinical Update ADAPTED FROM:
AHA Clinical Update ADAPTED FROM:
by layla
. 2022 AHA/ACC/HFSA Guideline for Heart Failure . ...
Human vs AIBased Echocardiography Analysis as Predictor of mortality i
Human vs AIBased Echocardiography Analysis as Predictor of mortality i
by smith
Federico M Asch, MD, FASE, FACC Director, CV Core ...
Complex Coronary Live Case Series
Complex Coronary Live Case Series
by nicole
In collaboration with. www.CCClivecases.org. ...
Prognostic Value of Programmed Electrical Stimulation Among Implantable
Prognostic Value of Programmed Electrical Stimulation Among Implantable
by jade
Cardioverter. -Defibrillator Recipients. Real-Worl...
Update Herzinsuffizienz Priv.-
Update Herzinsuffizienz Priv.-
by iris
Doz. . Dr. med. Sebastian Ewen. Universitätsklini...
AORTIC STENOSIS + AORTIC         REGURGITATION
AORTIC STENOSIS + AORTIC REGURGITATION
by susan2
Dr Monet Philipose. ...
x0000x0000   xMCIxD 0 xMCIxD 0  xMCIxD 1
x0000x0000 xMCIxD 0 xMCIxD 0 xMCIxD 1
by payton
ENHERTUSignificantlyImproved Both ProgressionFree ...
Dr  Smruti   Hindaria Assistant Professor
Dr Smruti Hindaria Assistant Professor
by morgan
CVTS. SURGICAL REVASCULARIZATION IN DEPRESSED CARD...
Management of Heart  Failure
Management of Heart Failure
by yvonne
Dr S Mazhar. Consultant Cardiologist. Southend uni...
Pr ospective Study  o f Biomarkers, Symptom Improvement and
Pr ospective Study o f Biomarkers, Symptom Improvement and
by brambani
V. entricular Remodeling During . E. ntresto Thera...
Pr ospective Study  o f Biomarkers, Symptom Improvement and
Pr ospective Study o f Biomarkers, Symptom Improvement and
by funname
V. entricular Remodeling During . E. ntresto Thera...
Pr ospective Study  o f Biomarkers, Symptom Improvement and
Pr ospective Study o f Biomarkers, Symptom Improvement and
by altigan
V. entricular Remodeling During . E. ntresto Thera...
Pharmacologic Profiles  of Approved and Investigational Oral
Pharmacologic Profiles of Approved and Investigational Oral
by kinohear
Anticoagulants.  . Warfarin. Dabigatran. Rivaroxa...
 Arrhythmia and Devices in HF
Arrhythmia and Devices in HF
by tawny-fly
Dr. . Amirhossein. . Azhari. . E. lectrophysio...
 Atrial Fibrillation Ablation in Heart Failure
Atrial Fibrillation Ablation in Heart Failure
by danika-pritchard
Avishag Laish-Farkash, MD, PhD. Director, EP and ...
New Technology and Applications in Nuclear Cardiology
New Technology and Applications in Nuclear Cardiology
by aaron
Todd D. Miller, M.D.. Mayo Clinic. Rochester, MN....
Prognostic Value of Programmed Electrical Stimulation Among
Prognostic Value of Programmed Electrical Stimulation Among
by tatiana-dople
Cardioverter. -Defibrillator Recipients. Real-Wor...
Deck for external distribution
Deck for external distribution
by tawny-fly
Created 2015-09-30. General Heart Failure. SE1510...
Diastolic LV function  and HFNEF
Diastolic LV function and HFNEF
by olivia-moreira
FRIJO JOSE A. Approximately . 50% of . pts . with...
Implantable
Implantable
by lindy-dunigan
Cardioverter. Defibrillators to Prevent Sudden C...
MUGA scans
MUGA scans
by danika-pritchard
&. monitoring of chemotherapy. Cardiovascular...
Indications for Surgical Intervention—Mitral Regurgitatio
Indications for Surgical Intervention—Mitral Regurgitatio
by trish-goza
Ryan Hampton. OMS IV. January 2015. Mitral Regurg...
Apical
Apical
by sherrill-nordquist
Rocking. and . cardiomyopathy. Current. . attem...
The Soluble Guanylate Cyclase Stimulator Vericiguat in Wors
The Soluble Guanylate Cyclase Stimulator Vericiguat in Wors
by alexa-scheidler
SOCRATES-REDUCED . D. ose Finding . P. hase II ....